Search is Powered by Google
Cancer / Oncology News

Minorities With Advanced Cancer Less Likely Than White Patients To Have Documented Preferences For End-Of-Life Care, Study Says

Main Category: Cancer / Oncology
Also Included In: Caregivers / Homecare
Article Date: 02 Oct 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Blacks and Hispanics who have advanced cancer are about one-third less likely than whites to have a plan, such as a living will or do-not-resuscitate order, that details their preferences for end-of-life care, according to a new study, Reuters reports. For the study, published in the Journal of Clinical Oncology, Alexander Smith of Beth Israel Deaconess Medical Center and colleagues examined interviews with 449 cancer patients who thought they had fewer than six months to live.

According to the study, 80% of white patients had either discussed end-of-life preferences with their doctors or had a plan in place, compared with 47% of both black and Hispanic patients.

Researchers found that minority patients with advanced cancer were more likely than white patients to want aggressive care to prolong their lives. They also were more likely than whites to say that religion was very important to them, the study found. However, those differences did not explain lower numbers of minorities who lacked an end-of-life care plan, the researchers said, adding that further studies are needed to explain the discrepancy.

They noted that previous research has indicated minorities are less likely to trust the health system and that could affect their desire to plan end-of-life care. Smith added that the way doctors communicate with patients about end-of-life care also could affect which patients develop a care plan (Reuters, 9/30).

An abstract of the study is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation.  All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...